Live Analyst Rating Changes 1515 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Ranulf Orr
Citi
Ranulf Orr
Citi
Wall Street Analyst
Not yet ranked — too few measurable calls.
0%
Success Rate
-14.9%
Average Return
0 of 1 calls profitable · -7.8% vs benchmark
📈 Across the calls we could measure, roughly 0% of Ranulf Orr's ratings turned a profit when each position was held for 1 year — averaging -14.9% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

10 Buy 15 Hold 1 Sell
Ranulf's Stock Coverage 20 ratings · 2026-06-19
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
NL:AKZA
Akzo Nobel NV
 Jun 05, 2026 BUY Strong Buy
+13.0% avg upside
12 analysts
$61.00
2.39% Upside
 ·
CH:CLN
Clariant AG
 Jun 05, 2026 HOLD Buy
+56.0% avg upside
10 analysts
$7.50
0.33% Downside
 ·
GB:0Q4U
Novonesis
 May 08, 2026 BUY Strong Buy
+9.6% avg upside
8 analysts
$440.00
15.11% Upside
 ·
CH:GIVN
Givaudan SA
 Mar 17, 2026 HOLD Buy
+11.3% avg upside
15 analysts
$3150.00
1.33% Downside
 ·
GB:TATE
Tate & Lyle
 Feb 27, 2026 BUY Buy
+4.0% avg upside
8 analysts
$500.00
9.41% Downside
 ·
FR:AKE
Arkema
 Dec 12, 2025 BUY Hold
+33.3% avg upside
9 analysts
$70.00
21.51% Upside
 ·
GB:0NZR
Solvay SA
 Dec 12, 2025 HOLD Buy
+94.8% avg upside
10 analysts
$26.00
6.63% Downside
 ·
GB:VCT
Victrex
 Dec 09, 2025 HOLD Hold
+2175.8% avg upside
9 analysts
$700.00
13.54% Upside
 ·
GB:JMAT
Johnson Matthey
 Dec 01, 2025 HOLD Strong Buy
+2119.6% avg upside
6 analysts
$2100.00
2.58% Downside
 ·
GB:CRDA
Croda International
 Oct 03, 2025 HOLD Strong Buy
+27.7% avg upside
9 analysts
$3050.00
3.17% Downside
 ·
GB:0RUY
Umicore SA
 Aug 07, 2025 HOLD Buy
-2.6% avg upside
6 analysts
$14.00
41.05% Downside
 ·
DE:SY1
Symrise
 Apr 25, 2025 BUY Strong Buy
+23.8% avg upside
16 analysts
$120.00
40.28% Upside
 ·
DE:BAS
BASF SE
 Sep 27, 2024 HOLD Buy
+16.4% avg upside
14 analysts
$44.00
9.42% Downside
 ·
GB:0O7D
Yara International
 Jan 18, 2024 BUY Hold
+3.1% avg upside
9 analysts
$430.00
5.84% Downside
 ·
DE:WCH
Wacker Chemie AG
 Nov 06, 2023 SELL Sell
-0.8% avg upside
10 analysts
$108.00
12.90% Upside
 ·
DE:1COV
Covestro
 Oct 17, 2023 BUY Buy
+1.6% avg upside
11 analysts
$58.00
3.41% Downside
 ·
DE:LXS
LANXESS
 Oct 11, 2023 HOLD Buy
+115.7% avg upside
12 analysts
$24.00
50.95% Upside
 ·
FR:AI
Air Liquide
 Aug 18, 2023 BUY Buy
+0.3% avg upside
16 analysts
$165.44
0.94% Downside
 ·
IFF
International Flavors & Fragrances
 Jul 20, 2021 BUY Strong Buy
+29.3% avg upside
27 analysts
 — -14.9%
NVZMY
Novonesis
 Aug 15, 2019 HOLD Sell
-9.2% avg upside
5 analysts
 — ·
🔒 15 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Ranulf Orr — Frequently Asked Questions
How accurate are Ranulf Orr's stock ratings?
Based on the calls 13Foresight could measure, about 0% of Ranulf's ratings were profitable over a one-year hold, with an average return of -14.9% per rating, or -7.8% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Ranulf ranked on 13Foresight?
Ranulf Orr is currently ranked unranked . Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Ranulf cover?
Ranulf most recently has ratings on NL:AKZA, CH:CLN, GB:0Q4U, CH:GIVN, GB:TATE, FR:AKE, GB:0NZR, GB:VCT, GB:JMAT, GB:CRDA, GB:0RUY, DE:SY1 and 8 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.